FBLG Insider Trading Activity and SEC Form 4 Filings
FBLG insider trading summary
Over the past 12 months, insiders at FibroBiologics, Inc. (FBLG) reported 7 open-market purchases worth $121K by 4 insiders and no sales on SEC Form 4. Net insider buying was $121K.
Latest FBLG insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 4, 2026 | Hamid Khoja | Chief Scientific Officer | Buy | $11K (30,000 @ $0.38) |
| Mar 4, 2026 | Pete O'Heeron | Chief Executive Officer | Buy | $6K (15,872 @ $0.38) |
| Mar 3, 2026 | Pete O'Heeron | Chief Executive Officer | Buy | $7K (18,200 @ $0.41) |
| Mar 2, 2026 | Jason Davis | Chief Financial Officer | Buy | $29K (70,000 @ $0.41) |
| Mar 2, 2026 | Pete O'Heeron | Chief Executive Officer | Buy | $6K (17,428 @ $0.35) |
| Feb 27, 2026 | Ruben A Garcia | General Counsel | Buy | $13K (40,000 @ $0.33) |
| Dec 11, 2025 | Ruben A Garcia | General Counsel | Buy | $48K (140,000 @ $0.34) |
| May 27, 2025 | Hamid Khoja | Chief Scientific Officer | Buy | $17K (20,000 @ $0.84) |
| Aug 12, 2024 | Hamid Khoja | Chief Scientific Officer | Buy | $19K (10,000 @ $1.90) |
| Aug 12, 2024 | Pete O'Heeron | Chief Executive Officer | Buy | $16K (8,500 @ $1.91) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.